Skip to main content

EVERSPIN TECHNOLOGIES INC

For the period ended Mar 31, 2025. Filed Apr 30, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed Apr 30, 2025

MRAM$12.92+10.1%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Notes to Condensed Financial Statements (unaudited)

Notes to Unaudited Condensed Financial Statement****s

1. Organization and Nature of Business

Everspin Technologies, Inc. (“we”, “our”, “us”, “Everspin Technologies”, “Everspin”, or the “Company”) was incorporated in Delaware on May 16, 2008. The Company’s magnetoresistive random-access memory (MRAM) solutions offer the persistence of non-volatile memory with the speed and endurance of random-access memory (RAM) and enable the protection of mission critical data particularly in the event of power interruption or failure. The Company’s MRAM solutions allow its customers in key markets, such as industrial, medical, automotive/transportation, aerospace and data center markets to design high performance, power efficient and reliable systems without the need for bulky batteries or capacitors.

2. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (GAAP) and applicable rules and regulations of the Securities and Exchange Commission (SEC) regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by GAAP have been condensed or omitted, and accordingly the balance sheet as of December 31, 2024, has been derived from the audited financial statements at that date but does not include all of the information required by GAAP for complete financial statements. These unaudited interim condensed financial statements have been prepared on the same basis as the Company’s annual financial statements and, in the opinion of management, reflect all adjustments (consisting only of normal recurring adjustments) that are necessary for a fair statement of the Company’s financial information. The results of operations for the three months ended March 31, 2025, are not necessarily indicative of the results to be expected for the year ending December 31, 2025 or for any other interim period or for any other future year.

The accompanying condensed financial statements and related financial information should be read in conjunction with the audited financial statements and the related notes thereto for the year ended December 31, 2024, included in the Company’s Annual Report on Form 10-K filed with the SEC.

Reclassifications

Certain reclassifications of previously reported amounts have been made to conform to the current period presentation. Specifically, interest income was previously presented within other income (expense), net for the three months ended March 31, 2024 in the Quarterly Report on Form 10-Q filed with the SEC on May 2, 2024. Interest income is presented separately in the unaudited condensed statement of operations and comprehensive loss within these financial statements.

Use of Estimates

The preparation of the condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, management evaluates its estimates, including those related to revenue recognition, fair value of assets and liabilities, inventory net realizable value, deferred tax assets and related valuation allowances, and stock-based compensation. The Company believes its estimates and assumptions are reasonable; however, actual results may differ from the Company’s estimates.

Segment Information

The Company’s MRAM technology solutions are sold as products and services through MRAM-based products, licenses and royalties of MRAM and magnetic sensor technology and backend foundry and design services. The Company identifies and manages the business activities inone reportable segment. The Company’s Chief Executive

Officer is the Chief Operating Decision Maker (CODM). The CODM utilizes the Company’s long-range plan, which includes product development roadmaps and long-range financial models, as a key input to resource allocation. The CODM makes decisions on resource allocation, assesses performance of the business, and monitors budget versus actual results using net income. Significant segment expenses within net income are those separately presented on the Company’s statements of operations and comprehensive loss, which include cost of sales, research and development, general and administrative, and sales and marketing expenses.

Cash and Cash Equivalents

The Company considers all highly liquid, short-term investments with maturity dates of 90 days or less at the date of purchase to be cash equivalents. The Company’s cash equivalents consist solely of money market funds.

Accounts Receivable, Net

The Company establishes an allowance for product returns. The Company analyzes historical returns, current economic trends and changes in customer demand and acceptance of products when evaluating the adequacy of sales returns. Returns are processed as credits on future purchases and, as a result, the allowance is recorded against the balance of trade accounts receivable. In addition, the Company, from time to time, may establish an allowance for estimated price adjustments related to its distributor agreements. The Company estimates credits to distributors based on the historical rate of credits provided to distributors relative to sales and evaluation of current market conditions.

Accounts receivable, net consisted of the following (in thousands):

​​​​​​​
​ · ​ · March 31, · ​ · December 31,
​ · ​ · 2025 · ​ · 2024
Trade accounts receivable​$12,794​$11,944
Unbilled accounts receivable​​196​​187
Allowance for product returns and price adjustments​​(425)​​(409)
Accounts receivable, net​$12,565$11,722
​​​​​​​

Concentration of Credit Risk

Financial instruments that potentially expose the Company to a concentration of credit risk consist principally of cash and cash equivalents that are held by a financial institution in the United States and accounts receivable. Amounts on deposit with a financial institution may at times exceed federally insured limits.

Significant customers are those which represent more than 10% of the Company’s total revenue or net accounts receivable balance at each respective balance sheet date. For the purposes of this disclosure, the Company defines “customer” as the entity that is purchasing the products or licenses directly from the Company, which includes the distributors of the Company’s products in addition to end customers that the Company sells to directly. For each significant customer, revenue as a percentage of total revenue and accounts receivable as a percentage of total accounts receivable, net are as follows:

​​​​​​​​​​​
​ · ​ · Revenue · ​ · Accounts Receivable
​ · ​ · Three Months Ended March 31, · ​ · March 31, · ​ · December 31,
Customers · 2025 · 2024 · 2025 · 2024
Customer A19%*​​19%*​
Customer B​*​21%​*​*​
Customer C​11%24%​37%61%
Customer D​11%*​​*​*​
​​​​​​​​​​​

*Less than 10%

Fair Value of Financial Instruments

Fair value is defined as an exit price, representing the amount that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. The framework for measuring fair value provides a three-tier hierarchy prioritizing inputs to valuation techniques used in measuring fair value as follows:

Level 1— Observable inputs such as quoted prices for identical assets or liabilities in active markets;

Level 2— Inputs, other than quoted prices for identical assets or liabilities in active markets, which are observable either directly or indirectly; and

Level 3— Unobservable inputs in which there is little or no market data requiring the reporting entity to develop its own assumptions.

The carrying value of accounts receivable, accounts payable, and other accruals readily convertible into cash approximate fair value because of the short-term nature of the instruments. The Company’s financial instruments consist of Level 1 assets. Where quoted prices are available in an active market, securities are classified as Level 1. Level 1 assets consist of highly liquid money market funds that are included in cash equivalents.

The following tables set forth the fair value of the Company’s financial assets and liabilities measured at fair value on a recurring basis (in thousands):

​​​​​​​​​​​​​
​ · ​ · March 31, 2025
​ · Level 1 · Level 2 · Level 3 · Total
Assets: · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
Money market funds​$33,613$—$—$33,613
Total assets measured at fair value​$33,613$—$—$33,613
​​​​​​​​​​​​​
​​​​​​​​​​​​​
​ · ​ · December 31, 2024
​ · Level 1 · Level 2 · Level 3 · Total
Assets: · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
Money market funds​$33,617$—$—$33,617
Total assets measured at fair value​$33,617$—$—$33,617
​​​​​​​​​​​​​

Recently Adopted Accounting Pronouncements

The Company adopted Accounting Standards Update (ASU) 2023-09,Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which improves income tax disclosure requirements, primarily through disaggregated information about effective income tax rate reconciliation and additional disclosures regarding income taxes paid. The guidance is effective for fiscal years beginning after December 15, 2024, and interim periods within fiscal years beginning after December 15, 2024.

The Company adopted ASU 2023-09 effective January 1, 2025, on a prospective basis. The adoption of ASU 2023-09 did not have a significant impact to the condensed financial statements.

Recently Issued Accounting Pronouncements Under Evaluation

In November 2024, the Financial Accounting Standards Board (FASB) issued ASU 2024-03,Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Topic 220): Disaggregation of Income Statement Expenses, which requires additional disclosure of certain amounts included in the expense captions presented on the statement of operations, as well as disclosures about selling expenses. ASU 2024-03 is effective for the Company’s annual reporting periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027, on a prospective basis, with the option for retrospective application. Early adoption is permitted for annual financial statements that have not yet been issued. The Company is currently evaluating the impact that the standard will have on its condensed financial statements.

The Company reviewed all other recently issued accounting pronouncements and concluded that they were either not applicable or not expected to have a significant impact to the condensed financial statements.

3. Statements of Operations and Comprehensive Loss Components

Revenue

The Company sells products to its distributors, original design manufacturers (ODMs), and original equipment manufacturers (OEMs). The Company also recognizes revenue under licensing, patent, and royalty agreements with some customers.

The following table presents the Company’s revenues disaggregated by sales channel (in thousands):

​​​​​​​
​ · ​ · Three Months Ended March 31,
​ · 2025 · 2024
Distributor​$7,918​$10,287
Non-distributor​​5,220​​4,143
Total revenue​$13,138​$14,430
​​​​​​​

The following table presents the Company’s revenues disaggregated by timing of recognition (in thousands):

​​​​​​​
​ · ​ · Three Months Ended March 31,
​ · 2025 · 2024
Point in time​$11,158​$10,967
Over time​​1,980​​3,463
Total revenue​$13,138​$14,430
​​​​​​​

The following table presents the Company’s revenues disaggregated by type (in thousands):

​​​​​​​
​ · ​ · Three Months Ended March 31,
​ · 2025 · 2024
Product sales​$11,026​$10,860
Licensing​​511​​3,221
Royalties​​132​​107
Other revenue​​1,469​​242
Total revenue​$13,138​$14,430
​​​​​​​

The Company recognizes revenue inthree primary geographic regions: Asia-Pacific (APAC); North America; and Europe, Middle East and Africa (EMEA). The Company recognizes revenue by geography based on the region in which the Company’s products are sold, and not to where the end products in which they are assembled are shipped. The Company’s revenue by region for the periods indicated was as follows (in thousands):

​​​​​​​
​ · ​ · Three Months Ended March 31,
​ · 2025 · 2024
APAC​$7,259​$6,930
North America​​2,483​​4,708
EMEA​​3,396​​2,792
Total revenue​$13,138​$14,430
​​​​​​​

Other Income (Expense), Net

On August 14, 2024, the Company received a strategic award to develop a long-term plan to provide manufacturing services for aerospace and defense segments (the Award). Under the Award, the Company will provide a plan to mitigate risks to its MRAM manufacturing supply chain. Pursuant to the Award, the Company may receive cash payments upon

the achievement of certain technical tasks and deliverables. The Award allows for milestones totaling up to approximately $14.6 million for the Company over a span of 2.5 years.

The Award is not in the ordinary course of the Company’s business and hence not a contract with a customer. The Company has applied the revenue recognition principles under Accounting Standards Codification 606 by analogy.

During the three months ended March 31, 2025, the Company billed $1.0 million relating to the Award and recorded $0.4 million of other income. The Company has recorded this other income using an input method based on costs incurred to date relative to the total expected costs of the Award over its term. The remaining $0.6 million of the billed amount for the Award is recorded as contract obligations liability on the condensed balance sheets. This amount represents the Company’s obligation to perform future services for which the Company has received or is entitled to receive payment but which are not yet fulfilled.

4. Balance Sheet Components

Inventory

Inventory consisted of the following (in thousands):

​​​​​​​
​ · ​ · March 31, · ​ · December 31,
​ · 2025 · 2024
Raw materials​$157​$238
Work-in-process​9,120​7,510
Finished goods​1,714​1,362
Total inventory​$10,991​$9,110
​​​​​​​

Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):

​​​​​​​
​ · ​ · March 31, · ​ · December 31,
​ · 2025 · 2024
Manufacturing equipment​$14,814​$14,199
Computer and network equipment​​608​​602
Furniture and fixtures​​113​​113
Construction in Progress​​144​​—
Leasehold improvements​​1,476​​1,476
Total property and equipment, gross​​17,155​​16,390
Less: accumulated depreciation​​(13,484)​​(13,170)
Total property and equipment, net​$3,671​$3,220
​​​​​​​

Depreciation and amortization expense during the three months ended March 31, 2025 and 2024 was $0.4 million and $0.4 million, respectively.

Intangible Assets, Net

The gross carrying amounts and accumulated amortization of intangible assets are as follows at the dates indicated (in thousands):

​​​​​​​​​​​​
​ · ​ · March 31, 2025
​ · ​ · Weighted- · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · Average · ​ · ​ · ​ · ​ · ​ · ​ · Net
​ · ​ · Life · ​ · ​ · Gross Carrying · ​ · Accumulated · ​ · Carrying
​ · ​ · (in years) · ​ · Amount · Amortization · Amount
Internal-use software​1.8​$4,389​$(1,416)​$2,973
Total intangible assets​​​$4,389​$(1,416)​$2,973
​​​​​​​​​​​​
​​​​​​​​​​​​
​ · ​ · December 31, 2024
​ · ​ · Weighted- · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · Average · ​ · ​ · ​ · ​ · ​ · ​ · Net
​ · ​ · Life · ​ · ​ · Gross Carrying · ​ · Accumulated · ​ · Carrying
​ · ​ · (in years) · ​ · Amount · Amortization · Amount
Internal-use software​2.0​$4,389​$(973)​$3,416
Total intangible assets​​​$4,389​$(973)​$3,416
​​​​​​​​​​​​

Amortization expense for the intangible assets was $0.4 million andzero for the three months ended March 31, 2025 and 2024, respectively.

Accrued Liabilities

Accrued liabilities consisted of the following (in thousands):

​​​​​​​
​ · ​ · March 31, · ​ · December 31,
​ · 2025 · 2024
Payroll-related expenses​$882​$1,606
Inventory​​466​​157
Other​1,208​686
Total accrued liabilities​$2,556​$2,449
​​​​​​​

Deferred Revenue

In March 2025, the Company renewed a contractual arrangement with a customer for the development of a strategic radiation hardened (“RAD-Hard”) field programmable gate array product. The total consideration in the arrangement is $1.2 million. The Company is recognizing revenue related to the performance obligation over time using the input method based on costs incurred to date relative to the total expected costs of the contract and began recognizing revenue in the first quarter of 2025. As of March 31, 2025, the Company has billed $0.2 million for the performance under the agreement and has recognized $0.1 million in revenue for the three months ended March 31, 2025, with the $0.1 million difference in deferred revenue. The Company expects to recognize the remaining $0.1 million of the transaction price as services are performed throughout the contractual period and performance is expected to be complete in the year ended December 31, 2025.

The Company concluded this contractual arrangement represents one arrangement and evaluated its promises to the customer and whether the performance obligations granted under the arrangement were distinct. The licenses provided to the customer are not transferable, are of limited value without the promised development services, and the customer cannot benefit from the license agreements without the specific obligated services in the development subcontract, as there is strong interdependency between the licenses and the development subcontract. Accordingly, the Company determined the licenses were not distinct within the context of the contract and combined the license with other performance obligations.

In January 2025, the Company executed a contractual arrangement with a customer to provide engineering services supporting the customer’s development that uses capabilities of MRAM for in-memory computing. The total consideration in the arrangement is $4.1 million. The Company is recognizing revenue related to the performance obligation over time using the input method based on costs incurred to date relative to the total expected costs of the contract and began recognizing revenue in the first quarter of 2025. As of March 31, 2025, the Company has billed $2.2 million for the performance under the agreement and has recognized $1.2 million in revenue for the three months ended March 31, 2025, with the $1.0 difference in deferred revenue. The Company expects to recognize the remaining $1.0 million of the transaction price as services are performed throughout the contractual period and performance is expected to be complete in the year ended December 31, 2025.

The Company concluded that this contractual arrangement represents one arrangement and assessed the nature of the promises made to the customer to determine whether the performance obligations were distinct. The Company determined that the engineering services are not separately identifiable from the promised development services, as the engineering services are highly interrelated with, and dependent upon, the overall development services over the life of the contract. Accordingly, the Company concluded that the engineering services are not distinct within the context of the contract and, therefore, should be combined with the other promised services into a single performance obligation.

5. Leases

Operating leases consist primarily of office space and manufacturing facilities expiring at various dates through 2029. Finance leases relate to server leases expiring at various dates through 2029. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.

The undiscounted future non-cancellable lease payments under the Company’s operating and finance leases were as follows (in thousands):

​​​​
As of March 31, 2025 · Amount
Remainder of 2025​$1,112
2026​​1,497
2027​​1,380
2028​​595
Thereafter​​46
Total lease payments​​4,630
Less: imputed interest​​(309)
Total lease liabilities​​4,321
Less: current portion of lease liabilities​​(1,323)
Total lease liabilities, net of current portion​$2,998
​​​​

Other information related to the Company’s operating lease liabilities was as follows:

​​​​​​​
​ · ​ · March 31, · ​ · December 31,
​ · 2025 · 2024
Weighted-average remaining lease term (years)3.16​​3.39
Weighted-average discount rate​4.50%​4.50%
​​​​​​​

Other information related to the Company’s finance lease liabilities was as follows:

​​​​​​​
​ · ​ · March 31, · ​ · December 31,
​ · 2025 · 2024
Weighted-average remaining lease term (years)3.92​​4.15
Weighted-average discount rate​3.90%​3.90%
​​​​​​​

6. Stock-Based Compensation

Share-Based Compensation Expense

The following table presents the details of the Company’s share-based compensation expense (in thousands):

​​​​​​​
​ · ​ · Three Months Ended March 31,
​ · ​ · 2025 · 2024
General and administrative​$717​$980
Research and development​​497​​580
Sales and marketing​​177​​154
Cost of sales​​186​​—
Total stock-based compensation​$1,577​$1,714
​​​​​​​

Summary of Stock Option Activity

The following table summarizes the stock option activity for the three months ended March 31, 2025:

​​​​​​​​​​​
​ · ​ · Options Outstanding
​ · ​ · ​ · ​ · Weighted- · ​ · Weighted- · ​ · ​ · ​
​ · ​ · ​ · ​ · Average · ​ · Average · ​ · Aggregate
​ · ​ · ​ · ​ · Exercise · ​ · Remaining · ​ · Intrinsic
​ · ​ · Number of · ​ · Price Per · ​ · Contractual · ​ · Value
​ · ​ · Options · Share · Life (years) · (In thousands)
Balance—December 31, 20241,521,857​$6.045.9​$1,507
Options granted​—​​​​​​​​
Options exercised(10,620)​​2.75​​​$31
Options cancelled/forfeited(2,126)​​7.49​​​​​
Balance—March 31, 20251,509,111​$6.06​5.7​$671
Options exercisable—March 31, 2025​1,407,156​$5.94​5.6​$671
​​​​​​​​​​​

The total grant date fair value of options vested was $0.2 million and $0.3 million during the three months ended March 31, 2025 and 2024, respectively.

No options were granted in the three months ended March 31, 2025 or 2024.

As of March 31, 2025, there was $0.5 million of total unrecognized stock-based compensation expense related to unvested options which is expected to be recognized over a weighted-average period of 0.91 years. Stock-based compensation cost for options capitalized within inventory at March 31, 2025 and 2024 was not material.

2016 Employee Stock Purchase Plan

In January 2025, there was an increase of 220,596 shares reserved for issuance under the Company’s Employee Stock Purchase Plan (ESPP) pursuant to the terms of the ESPP. The Company had 1,252,396 shares available for future issuance under the Company’s ESPP as of March 31, 2025. Employees did not purchase any shares during the three months ended March 31, 2025 and 2024.

Restricted Stock Units

The following table summarizes restricted stock units (RSUs) activity for the three months ended March 31, 2025:

​​​​​​
​ · ​ · RSUs Outstanding
​ · ​ · ​ · Weighted-
​ · ​ · ​ · Average
​ · ​ · Number of · Grant Date
​ · ​ · Restricted Stock · Fair Value Per
​ · Units · Share
Balance—December 31, 2024​987,965​$7.89
Granted781,336​$5.71
Vested​(281,828)​$7.28
Cancelled/forfeited​(4,853)​$6.85
Balance—March 31, 20251,482,620$6.86
​​​​​​

The fair value of RSUs is determined on the date of grant based on the market price of the Company’s common stock on that date.

As of March 31, 2025, there was$9.4 million of unrecognized stock-based compensation expense related to RSUs to be recognized over a weighted-average period of 2.4 years. Stock-based compensation cost related to RSUs capitalized within inventory at March 31, 2025 and 2024 was not material.

7. Significant Agreements

GLOBALFOUNDRIES, Inc. Joint Development Agreement

Since October 17, 2014, the Company has participated in a joint development agreement (JDA) with GLOBALFOUNDRIES Inc. (GLOBALFOUNDRIES), a semiconductor foundry, for the joint development of Spin-transfer Torque MRAM (STT-MRAM), technology to produce a family of discrete and embedded MRAM technologies. The term of the JDA is until the completion, termination, or expiration of the last statement of work entered into pursuant to the JDA. The JDA was extended on December 31, 2019, to include a new phase of support for 12nm MRAM development.

Under the current JDA extension terms, each party licenses its relevant intellectual property to the other party. For certain jointly developed works, the parties have agreed to follow an invention allocation procedure to determine ownership. In addition, GLOBALFOUNDRIES possesses the exclusive right to manufacture the Company’s discrete and embedded STT-MRAM devices developed pursuant to the JDA until the earlier ofthree years after the qualification of the MRAM device for a particular technology node orfour years after the completion of the relevant statement of work under which the device was developed. For the same exclusivity period associated with the relevant device, GLOBALFOUNDRIES agreed not to license intellectual property developed in connection with the JDA to named competitors of the Company.

If GLOBALFOUNDRIES manufactures, sells, or transfers to customers wafers containing production quantified STT-MRAM devices that utilize certain design information, GLOBALFOUNDRIES will be required to pay the Company a royalty.

8. Net (Loss) Income Per Common Share

Basic net (loss) income per common share is calculated by dividing the net (loss) income by the weighted-average number of shares of common stock outstanding for the period less shares subject to repurchase, without consideration of potentially dilutive securities. Diluted earnings per share is calculated using the treasury stock method by dividing net (loss) income by the total weighted average shares of common stock outstanding in addition to the potential impact of dilutive securities including restricted stock units, warrants, and options. In periods with a net loss, potentially dilutive securities are excluded from the Company’s calculation of earnings per share as their inclusion would have an antidilutive effect.

The following tables set forth the computation of basic and diluted net (loss) income per share attributable to common stockholders (in thousands, except share and per share amounts):

Basic and diluted EPS

​​​​​​​​
​ · ​ · ​ · Three Months Ended March 31,
​ · 2025 · 2024
Numerator: · ​ · ​
Net loss​​$(1,166)​$(202)
Net income attributable to common stockholders, diluted​​$(1,166)​$(202)
Denominator:​​​
Weighted-average shares of common stock outstanding, basic​​22,188,114​21,252,359
Weighted-average shares of common stock outstanding, diluted​​22,188,114​21,252,359
Net loss per common share, diluted​​$(0.05)​$(0.01)
​​​​​​​​

Potentially dilutive securities representing 1.8 million and 1.5 million stock options and RSUs that were outstanding during the three months ended March 31, 2025, and 2024, respectively, were excluded from the computation of diluted earnings per common share during these periods as their inclusion would have an antidilutive effect.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.